Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Onewo’s US$738 Million Hong Kong IPO
Paul Hastings and JunHe advised Onewo Inc. on the deal. Herbert Smith Freehills advised CITIC Securities, Citigroup and Goldman Sachs as joint sponsors. Onewo Inc. announced its approximately...
Linmon Media Limited’s HK$420 Million Initial Public Offering
Harneys acted as Cayman Islands counsel to Linmon Media Limited on the matter. Clifford Chance provided Hong Kong and US legal advice and CM Law Firm...
Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
Yunkang Group Limited’s $140 Million Hong Kong Listing
Kirkland & Ellis and Zhong Lun advised Yunkang Group Limited on the deal. Herbert Smith Freehills advised CMB International Capital Limited and SPDB International Capital Limited....
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Bio-heart Biological Technology Co. Ltd.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills has advised Huatai Financial Holdings (Hong Kong) Limited. O’Melveny & Myers represented Bio-heart on the deal. Huatai Financial Holdings (Hong Kong) Limited acted...
Brii Biosciences’ US$318 Million Hong Kong IPO
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....
MMG Limited’s US$302.16 Million Placement
Herbert Smith Freehills advised MMG Limited (01208.HK) on the deal. MMG Limited (01208.HK) placed new shares on the Hong Kong Stock Exchange. MMG Limited is a...
Peijia Medical Limited’s Listing On The Hong Kong
Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors. O’Melveny & Myers LLP and and Jingtian & Gongcheng advised...